Indonesia: Updates to IVD Product Categories, Product Types and Risk Classes

The Ministry of Health has issued Circular Letter No. FR.03.01/E.V/2204/2026, introducing changes to the categories, subcategories, product types, and risk classifications of In Vitro Diagnostic medical devices (IVDs).

The updates are intended to align IVD product nomenclature with applicable international classification references and improve product identification and grouping through the introduction of more specific product types.

Read the full Circular Letter here: Circular Letter No. FR.03.01/E.V/2204/2026 regarding Changes to the Categories, Subcategories, Product Types, and Risk Classes of In Vitro Diagnostic Medical Devices (IVDs). (PDF)

The document is available in Indonesian only. English translation is currently not available.

Purpose of the Update

To revise the existing IVD classification framework by updating product categories, subcategories, product types, and risk classes.

The changes also introduce more specific product nomenclature to support clearer product identification and grouping.

Key Updates

The Circular Letter and its annex introduce the following changes:

  1. Updates to IVD categories, subcategories, product types, and risk classifications as specified in the annex.
  2. Alignment of product nomenclature with applicable international classification references.
  3. Introduction of more specific product types compared with the previous nomenclature.
  4. Continued validity of existing Product Approval Licenses issued under the previous nomenclature until their respective expiry dates.
  5. An option for Product Approval License holders to update product-type nomenclature through a variation application or renewal application involving changes to the license, in accordance with applicable regulations.

Notable Classification Changes

The annex identifies 16 classification updates. Notable changes include:

Product GroupKey Change
Hepatitis B and C TestsNew specific product types have been established for serological testing and nucleic acid testing (NAT), based on test methodology and intended use.
HIV TestsNew specific product types have been introduced for viral load monitoring, serological diagnosis, and NAT-based diagnosis.
Respiratory Pathogen TestsA multiplex nucleic acid assay product type has been reclassified from Risk Class B to Risk Class C.
Immunohistochemistry (IHC) Reagents and KitsRisk classifications have changed to Class C for the listed qualitative and quantitative products.
Tuberculosis (MTBC) Nucleic Acid TestsRisk classification has changed from Class B to Class C for the listed products.
Immunology CalibratorsProduct types for strip and liquid calibrators have been consolidated under more specific immunology-related product classifications.

Existing Product Approval Licenses

Product Approval Licenses (Nomor Izin Edar / NIE) issued before implementation of the updated classifications and referring to the previous product-type nomenclature will remain valid until their respective expiry dates.

License holders may update the relevant product-type nomenclature through:

  • A variation application; or
  • A renewal application involving changes to the license

These updates must be submitted in accordance with the applicable regulatory requirements.

Implications to Clients

Manufacturers, authorised representatives, importers, and distributors should review their existing IVD registrations against the revised nomenclature and risk classifications.

In particular, companies should consider whether the changes may affect:

  • Future amendments or variation applications
  • Renewal submissions
  • New product registrations
  • Product classification strategy
  • Supporting registration documentation

Existing licenses do not need to be replaced immediately solely because of the updated classification framework, as they remain valid until expiry.

Where an existing product is affected by the revised nomenclature or risk classification, the relevant updates may be addressed through the applicable variation or renewal process.

For Inquiries

For inquiries or support regarding medical device regulatory requirements in Indonesia, please contact sales@andamanmed.com.

Sign up for our regulatory roundup delivered once a month to your inbox

Scroll to Top

Contact Us

Contact Form Demo